Speak directly to the analyst to clarify any post sales queries you may have.
The usage of genetic testing in the US is increasing due to the increasing curiosity regarding ancestry testing. This test provides more information regarding the people's origin in terms of geography. The number of genetic disorders impacting people is increasing in the US. This is increasing the number of people undergoing DTC testing due to the increased awareness regarding the testing and preventive measures. DTC testing provides better information regarding nutrition, medicine, personalized therapies, and more.
KEY HIGHLIGHTS
- In the US, genetic tests are usually done for multipurpose, as they are not mutually exclusive. The number of genetic tests is increasing over time
- Around 90% of genetic tests carried out are for clinical purposes. Only a limited number of genetic tests are performed for research purposes. The increasing disease population will increase the demand for DTC testing in the market as a part of preventive care.
- The increasing demand for personalized nutrition and medicine is increasing the demand for DTC in the market, especially among celebrities and bodybuilders.
- At-home DNA ancestry testing provides complete information about one’s family lineage by analysing their genetic code and by comparing it with millions of other people’s DNA. The test is usually done with a saliva sample. The current generation of the US is more curious to know about their family history.
- 23andMe is the only US FDA that has approved DTC tests for cancer patients. The DTC test has increased the number of people undergoing cancer tests. Some of the companies are providing consultations regarding genetic testing through telehealth platforms.
- People prefer for subscription model of genetic testing in the market. The longer the subscription more detailed results for the sequences are provided. This provides more personalized solutions to the patients
VENDORS LIST
Key Vendors
- Ancestry
- 23andME
Other Prominent Vendors
- 24GENETICS
- Molecular vision
- Dante Genomics
- Living DNA
- Family Tree DNA
- FullGenomes
- Genebase
- MyHeritage
- NebulaGenomics
- Veritas
- Homedna
- ColorHealth
- Nucleus
SEGMENTATION & FORECAST
- Test Type
- Ancestry & Relationship
- Predictive Testing
- Nutrigenomics
- Carrier Testing
- Others
- Technology
- Single Nucleotide polymorphism
- Whole Genome Sequencing
- Targeted Analysis
- Distribution Channel
- Online
- Offline
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape
- Key Vendors
- Other Prominent Vendors
- Strategic Recommendations
- Quantitative Summary
- Abbreviations
APPENDIX
- Research Methodology
- Abbreviations
- About the Analyst
Table of Contents
Companies Mentioned
- Ancestry
- 23andME
- 24GENETICS
- Molecular vision
- Dante Genomics
- Living DNA
- Family Tree DNA
- FullGenomes
- Genebase
- MyHeritage
- NebulaGenomics
- Veritas
- Homedna
- ColorHealth
- Nucleus
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 74 |
| Published | October 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 0.89 Billion |
| Forecasted Market Value ( USD | $ 1.65 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | United States |
| No. of Companies Mentioned | 15 |
